Needham analyst Serge Belanger initiated coverage of Ocular Therapeutix (OCUL) with a Buy rating and $15 price target citing Axpaxli’s potential as a “paradigm-changing wAMD treatment.” ...

Crohn’s-related eye disorders can be painful. In rare cases, they can lead to vision loss. In rare cases, you may develop inflammation in other parts of the eye, including the retina and optic ...

Osteo-odonto keratoprosthesis, more commonly known as “tooth-in-eye” surgery, involves harvesting the body’s strongest natural substance to craft a specialized lens implant for patients with ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Have you ever locked eyes with someone and wondered how rare their eye color is?